An interventional study of Personalized OSA messages and Control in Obstructive Sleep Apnea, sponsored by Brigham and Women's Hospital. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-10-02.
Sponsored by Brigham and Women's Hospital · Not applicable, Interventional, and Supportive care
How we know · 2 judgments
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 42 studies in Sleep Apnea, Obstructive by Brigham and Women's Hospital — 12 open to participants now, 12 under way, none of them phase 3. Sleep Apnea, Obstructive · Brigham and Women's Hospital.
Among the 42 studies in Sleep Apnea, Obstructive by Brigham and Women's Hospital, this one is the 14th largest by enrollment, is one of 3 that started in 2022, is one of 19 with no phase, and was the 30th registered.
2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.
Browse Sleep Apnea, Obstructive studies →12 of the 42 studies in Sleep Apnea, Obstructive by Brigham and Women's Hospital are open now, in 1 country. Recruiting first, the newest first:
Brigham and Women's Hospital · Sites in United States
Ages 18+
Brigham and Women's Hospital · Sites in United States
Ages 18–79
Brigham and Women's Hospital · Sites in United States
Ages 21–70
Brigham and Women's Hospital · Sites in United States
Ages 21–70
Brigham and Women's Hospital · Sites in United States
Ages 5–18
By country, each count listing its studies:
Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.
This study: all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
42 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 15 · Phase 2 21
First in 2004; this study’s year is marked. 3 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 38 is below the median of 52 across 1,476 interventional studies indexed under Sleep Apnea, Obstructive.
Median enrollment 22 across the 42 interventional studies. Of the 28 that completed or were terminated, 18 (64%) have results posted.
This tab as a report to print or save as PDF → With an account.
Brigham and Women's Hospital is the lead sponsor of 1,270 studies on the registry; 230 are open to participants now.
Of its 117 completed or terminated interventional studies of FDA-regulated products, 65 (56%) have results posted.
3 of the studies in Sleep Apnea, Obstructive by Brigham and Women's Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05350215Brigham and Women's HospitalAtomoxetine and DAW2022 on OSA Severity | 2026-12-01 |
| NCT06854211Brigham and Women's HospitalImpacts of Opioids on Respiratory Drive During Sleep | 2027-01-01 |
| NCT06043440Brigham and Women's HospitalDown Syndrome Obstructive Sleep Apnea | 2027-11-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 42 studies in Sleep Apnea, Obstructive by Brigham and Women's Hospital, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The objective of this protocol is to conduct a focus group to identify OSA beliefs, attitudes, and knowledge among employees in the transportation industry on shift schedules.
Transportation shift workers (TSW, e.g., overnight, on-call, or rotating) have been identified as a high-risk group for health conditions (e.g., obesity, cardiovascular disease). Also, TSW are at risk for obstructive sleep apnea (OSA). According to one study, approximately 36% of TSWs have OSA, a condition that exacerbates health risks and daytime sleepiness. A recent report from the American Academy of Sleep Medicine (AASM) showed that those with untreated OSA cost on average $4,261 more than those without OSA. Also concerning, workers with OSA who are non-adherent to recommended OSA treatment (i.e., continuous positive airway pressure, CPAP) are at particularly high risk for motor vehicle accidents compared to those who are adherent.
This protocol outlines focus groups that will aim to identify knowledge, attitudes, and beliefs about OSA among TSW. Results of these focus groups will be used in future research to design a tailored website for relaying OSA information to TSW.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will receive the personalized OSA messages.
Behavioral: Personalized OSA messages
Placebo participants will receive no treatment during the experiment.
Other: Control
Participants will receive personalized OSA messages designed to nudge and navigate them toward evaluation and treatment for OSA. Participants will complete questionnaires at baseline and at study follow-up.
Participants will complete questionnaires at baseline and at study follow-up. At the end of the study period, participants will receive the OSA message intervention.
Obstructive Sleep Apnea (OSA) Self-efficacy
The Survey of Obstructive Sleep Apnea Functional Health Literacy (SOFHL) was administered, which includes two subscales, one for OSA Self-Efficacy and another for OSA Knowledge. The SOFHL can be scored by measuring the proportion of correct answers in each sub-scale (OSA Self-Efficacy and OSA Knowledge). The OSA Self-Efficacy subscale collects responses to 5 self-efficacy questions on 3-point scales from 1 "I am confident" to 2 "I am not sure" and 3 "I am not confident." Scores of 1 ("I am confident") indicate self-efficacy. To score OSA Self-Efficacy, the total number of questions that participants mark a response of "1" ("I am confident") are summed then divided by the total number of questions in the subscale (5) and multiplied by 100. The result is a total score with a minimum possible value of 0% and a maximum possible value of 100%. Lower scores (closer to 0%) indicate low OSA self-efficacy scores. Higher scores (closer to 100%) indicate higher OSA Self-efficacy.
Time frame: Baseline and follow-up (approximately 2 months)
OSA Knowledge
The Survey of Obstructive Sleep Apnea Functional Health Literacy (SOFHL) was administered, which includes two subscales, one for OSA Self-Efficacy and another for OSA Knowledge. The SOFHL can be scored by measuring the proportion of correct answers in each sub-scale (OSA Self-Efficacy and OSA Knowledge). The OSA Knowledge subscale collects responses to 13 knowledge questions on 3-point scale from 1 ("I am confident this is true") to 2 ("I am not sure") and 3 ("I am confident this is not true"). To score OSA Knowledge, the total number of responses of 1 "I am confident this is true" are summed then divided by 13 and multiplied by 100. The result is a score with a minimum possible value of 0% and a maximum possible value of 100%. Lower scores (closer to 0%) indicate lower OSA knowledge while higher scores (closer to 100%) indicate higher OSA Knowledge.
Time frame: Baseline and follow-up (approximately 2 months)
OSA Readiness to Change
OSA Readiness to Change: A measure of willingness to improve sleep and address sleep problems. OSA readiness to change will be measured with a 12-item questionnaire. Responses are captured on a 5-item scale from 1 "strongly disagree" to 5 "strongly agree." Responses are summed for a total score of readiness to change. Higher scores indicate higher levels of readiness to change.
Time frame: Baseline and follow-up (approximately 2 months)
Participants (n=38) were randomized at the worksite level to intervention (n=18) or control (n=20).
| Milestone | Intervention | Control |
|---|---|---|
| Started | 18 | 20 |
| Completed | 18 | 20 |
| Not completed | 0 | 0 |
The Survey of Obstructive Sleep Apnea Functional Health Literacy (SOFHL) was administered, which includes two subscales, one for OSA Self-Efficacy and another for OSA Knowledge. The SOFHL can be scored by measuring the proportion of correct answers in each sub-scale (OSA Self-Efficacy and OSA Knowledge). The OSA Self-Efficacy subscale collects responses to 5 self-efficacy questions on 3-point scales from 1 "I am confident" to 2 "I am not sure" and 3 "I am not confident." Scores of 1 ("I am confident") indicate self-efficacy. To score OSA Self-Efficacy, the total number of questions that participants mark a response of "1" ("I am confident") are summed then divided by the total number of questions in the subscale (5) and multiplied by 100. The result is a total score with a minimum possible value of 0% and a maximum possible value of 100%. Lower scores (closer to 0%) indicate low OSA self-efficacy scores. Higher scores (closer to 100%) indicate higher OSA Self-efficacy.
| Scores on a scale | Intervention | Control |
|---|---|---|
| Baseline | 53.3 ± 24.7 | 47.0 ± 31.1 |
| Follow up | 56.7 ± 29.3 | 43.5 ± 32.6 |
The Survey of Obstructive Sleep Apnea Functional Health Literacy (SOFHL) was administered, which includes two subscales, one for OSA Self-Efficacy and another for OSA Knowledge. The SOFHL can be scored by measuring the proportion of correct answers in each sub-scale (OSA Self-Efficacy and OSA Knowledge). The OSA Knowledge subscale collects responses to 13 knowledge questions on 3-point scale from 1 ("I am confident this is true") to 2 ("I am not sure") and 3 ("I am confident this is not true"). To score OSA Knowledge, the total number of responses of 1 "I am confident this is true" are summed then divided by 13 and multiplied by 100. The result is a score with a minimum possible value of 0% and a maximum possible value of 100%. Lower scores (closer to 0%) indicate lower OSA knowledge while higher scores (closer to 100%) indicate higher OSA Knowledge.
| Scores on a scale | Intervention | Control |
|---|---|---|
| Baseline | 42.7 ± 18.3 | 49.2 ± 26.3 |
| Follow up (2 months) | 58.3 ± 21.6 | 50.7 ± 25.1 |
OSA Readiness to Change: A measure of willingness to improve sleep and address sleep problems. OSA readiness to change will be measured with a 12-item questionnaire. Responses are captured on a 5-item scale from 1 "strongly disagree" to 5 "strongly agree." Responses are summed for a total score of readiness to change. Higher scores indicate higher levels of readiness to change.
| Scores on a scale | Intervention | Control |
|---|---|---|
| Baseline | 6.2 ± 2.1 | 6.7 ± 1.9 |
| Follow up (2 months) | 7.2 ± 1.3 | 6.6 ± 2.6 |
Collected over Baseline to 2 months follow-up. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Intervention | 0/18 (0%) | 0/18 (0%) | 0/18 (0%) |
| Control | 0/20 (0%) | 0/20 (0%) | 0/20 (0%) |
| Age, Continuous(Age, years) | Intervention | Control | Total |
|---|---|---|---|
| Mean | 43.9 ± 12.01 | 42.8 ± 12.5 | 43.4 ± 12.1 |
| Sex: Female, Male(Participants) | Intervention | Control | Total |
|---|---|---|---|
| Female | 5 | 0 | 5 |
| Male | 13 | 20 | 33 |
| Race/Ethnicity, Customized(Participants) | Intervention | Control | Total |
|---|---|---|---|
| White/non-Hipsanic | 18 | 17 | 35 |
| Other | 0 | 2 | 2 |
| Did not respond | 0 | 1 | 1 |
| OSA Self-Efficacy(Scores on a scale) | Intervention | Control | Total |
|---|---|---|---|
| Mean | 53.5 ± 24.7 | 47.0 ± 31.3 | 50 ± 28.1 |
| OSA Knowledge(Scores on a scale) | Intervention | Control | Total |
|---|---|---|---|
| Mean | 42.7 ± 18.0 | 49.2 ± 26.3 | 45.3 ± 22.4 |
| OSA Readiness to Change(Scores on a scale) | Intervention | Control | Total |
|---|---|---|---|
| Mean | 6.2 ± 2.1 | 6.7 ± 1.9 | 6.4 ± 2.0 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Oct 2022 to primary completion in Jul 2024, 21 months.
Results were first posted in Oct 2026, 2 years 3 months after primary completion.
Of 511 non-industry interventional studies with no phase under Sleep Apnea, Obstructive, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's 21 months is below that.
Counting every sponsor, half of 629 studies reached it within 27 months; a quarter within 12 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Brigham and Women's Hospital →